ATI RN
Advanced Pharmacology Across the Lifespan Questions
Question 1 of 5
Which of the following diseases or disorders are most likely treated with ACE inhibitors?
Correct Answer: E
Rationale: I apologize for the error in the question. However, if we assume the correct answer is meant to be "D: Angina," the rationale is as follows: ACE inhibitors are commonly used to treat angina by dilating blood vessels, reducing blood pressure, and improving blood flow to the heart. Other choices are incorrect because ACE inhibitors are not typically used to treat hyperthyroidism, pulmonary hypertension, or Cushing's syndrome.
Question 2 of 5
A patient has a blood pressure of 150/95 mm HG and 148/90 mm Hg on two separate office visits. This is consistent with a blood pressure of 145/92 mm Hg taken in an ambulatory setting. The patient's diagnostic tests are all normal. What will the patient's provider order to best manage the patient's hypertension?
Correct Answer: A
Rationale: The correct answer is A: A thiazide diuretic. Thiazide diuretics are recommended as the initial medication for managing hypertension in patients without compelling indications. They are effective in lowering blood pressure by reducing the volume of circulating blood. In this case, the patient's blood pressure readings are consistently elevated, indicating the need for pharmacological management. Thiazide diuretics have been shown to reduce cardiovascular events and mortality in hypertensive patients. Loop diuretics and Spironolactone (Choice B) are not first-line treatments for hypertension and are typically used in specific cases like heart failure. Beta blockers (Choice C) are not the preferred initial treatment for hypertension in the absence of other compelling indications. Thus, the most appropriate choice for managing this patient's hypertension would be a thiazide diuretic.
Question 3 of 5
Which of the following groups of antibiotics finds to the 50S subunit of the bacterial ribosome and includes drugs such as Erythromycin and azithromycin?
Correct Answer: B
Rationale: The correct answer is B: Macrolides. Macrolides bind to the 50S subunit of the bacterial ribosome, inhibiting protein synthesis. Erythromycin and azithromycin are examples of macrolide antibiotics. The other choices are incorrect because: A: Fluoroquinolones inhibit bacterial DNA gyrase and topoisomerase IV. C: Aminoglycosides bind to the 30S subunit of the bacterial ribosome. D: Tetracyclines inhibit protein synthesis by binding to the 30S subunit of the bacterial ribosome.
Question 4 of 5
Acute bacterial rhinosinusitis syndrome (ABRS)
Correct Answer: C
Rationale: The correct answer is C (Streptococcus pneumoniae, Moraxella catarrhalis, Haemophilus influenzae) because these are the most common bacterial pathogens causing ABRS. Streptococcus pneumoniae is the most common, followed by Haemophilus influenzae and Moraxella catarrhalis. These bacteria are typically found in the upper respiratory tract and can cause infection when there is inflammation or blockage of the sinuses. The other choices are incorrect because they are not commonly associated with ABRS. Choice A includes bacteria commonly found in urinary tract infections. Choice B includes bacteria associated with hospital-acquired infections. Choice D includes bacteria that are more commonly associated with atypical pneumonia rather than sinus infections.
Question 5 of 5
_____ is an example of an agonist-antagonist opioid.
Correct Answer: D
Rationale: Step 1: Definition of agonist-antagonist opioid - It has both agonist (activates opioid receptors) and antagonist (blocks opioid receptors) properties. Step 2: Buprenorphine is a partial agonist opioid that activates and blocks opioid receptors. Step 3: Buprenorphine's agonist activity treats pain, while its antagonist activity reduces abuse potential. Step 4: Diprenorphine, Naloxone, and Morphine do not have both agonist and antagonist properties. Summary: Diprenorphine is a pure antagonist, Naloxone is a pure antagonist, and Morphine is a pure agonist, making them different from the agonist-antagonist opioid, Buprenorphine.